Intestinal parasitic infections caused by intestinal helminthes and protozoa are the most common human infections endemic throughout the world especially in tropical and subtropical countries including Nepal. This study was conducted to study the prevalence of intestinal parasites among patients visiting Sub-Regional Hospital, Dadeldhura, Nepal. Altogether 480 stool samples were collected from April 2017- October 2017. Microscopic examination of stool was done by using formal-ether concentration technique in the Microbiology Laboratory of Sub-Regional Hospital, Dadeldhura Nepal. The overall prevalence rate was found to be 10.625%. The prevalence of parasitic infection was higher in males (52.94%) than in females (47.06%). In the age group below 15 years, the prevalence was found to be higher (52.94 %) than other age groups. Total 6 species of intestinal parasites; 2 (33.33%) were protozoan parasites viz. cysts and trophozoites of Giardia lamblia, and cysts of Entamoeba histolytica, and 4 (66.67%) were helminths viz. ova of Ascaris lumbricoides, Trichuris trichuria, Hymenolepis nana, and Ancylostoma duodenale. The infection rate was found to be higher in people taking normal tap water. The study concluded that intestinal protozoan infection is still a public health problem of concern among the people of Dadeldhura. The prevalence of intestinal protozoan infection was found to be high in children and low educated groups in Dadeldhura. Thus, health education along with infection management actions and awareness programs for sanitation improvements are required to reduce protozoan infections.
Background The prevalence of extended-spectrum \(\beta\)-lactamase (ESBL) and AmpC \(\beta\)-lactamase (ABL) producing Enterobacteriaceae is increasing rapidly across the world. Members of Enterobacteriaceae like E. coli and Klebsiella spp. exhibit antimicrobial resistance mainly due to the production of beta-lactamase enzymes like extended-spectrum βlactamases, AmpC β-lactamases, and carbapenemases. These bacteria are frequently reported in sewage effluents of hospital and municipal sewerage systems indicating sewage as a promising source for dissemination of such drug-resistant pathogens. However, in most of the developing countries including Nepal, the major portion of sewage is discharged in water sources without proper treatment and disinfection. This study was undertaken to access the prevalence of ESBL and ABL producing E. coli and Klebsiella spp. in sewage effluents of Dharan, Nepal. Results A total of 235 bacteria were isolated, out of which 103 (43.83%) were E. coli and 132 (56.17%) were Klebsiella spp. ESBL production was seen in 157 (66.81%) isolates. Among them, 89 (56.69%) were Klebsiella spp. and 68 (43.31%) were E. coli. 66.02% of total isolated E. coli and 67.42% of total isolated Klebsiella spp. showed production of ESBL enzymes. ABL production was seen in 133 (56.59%) isolates. Among them, 54 (40.60%) were E. coli and 79 (59.40%) were Klebsiella spp. 52.43% of the isolated E. coli and 59.85% of isolated Klebsiella spp. were found producing ABL enzyme. Conclusions The results indicate that there is a high prevalence of ESBL and ABL producing E. coli and Klebsiella spp. in sewage effluents of Dharan. Effective treatment of sewage effluents must be ensured before discharging the sewage into the environment. National guidelines for discharging the municipal sewage must be immediately amended and an effective treatment system before discharge must be implemented. Dissemination of such drug-resistant bacteria in the human population leading to severe public health emergency is likely to occur from sewage contamination, so further study and surveillance and effective prevention and control measures are necessary.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.